Naccarato A G, Marcocci C, Miccoli P, Bonadio A G, Cianferotti L, Vignali E, Cipollini G, Viacava P
Dipartimento di Oncologia, Università di Pisa, Italy.
J Endocrinol Invest. 1998 Mar;21(3):136-41. doi: 10.1007/BF03347291.
An altered control of the mechanisms involved in cell proliferation and programmed cell death (apoptosis) might play an important role in parathyroid tumorigenesis. We evaluated by immunohistochemistry the expression of bcl-2 and p53 proteins, as markers of apoptosis control, and MIB-1, as marker of cell proliferation, in a series of normal and neoplastic parathyroid tissues. The specimens were 33 normal parathyroids, 43 parathyroid adenomas and 3 parathyroid carcinomas. Results were scored as positive when more than 1% of cells were stained for MIB-1 and p53, and more than 10% for bcl-2. All normal parathyroids showed numerous bcl-2 positive cells (> or = 80%), low proliferation rate (MIB-1) and no p53 protein expression. Twenty-four (55%) adenomas were bcl-2 positive; in 16 of these the number of positive cells was high (> 50%) and immunoreactivity was diffusely distributed within the adenoma; 8 cases showed a zonal staining pattern, in which groups of stained cells were surrounded by negative cells. Nineteen adenomas (45%) and all carcinomas were bcl-2 negative. A high proliferative rate (MIB-1) was found in all carcinomas and 4 adenomas (9%); all MIB-1 positive adenomas were bcl-2 negative. p53 was negative in all specimens. No significant differences in serum calcium and intact PTH levels nor in tumor size were found between bcl-2 negative and bcl-2-positive and MIB-1-positive and MIB-1-negative adenomas. An inverse, but not statistically significant (p = 0.06) correlation was observed between the percentage of bcl-2 positive cells and serum calcium level in parathyroid adenomas. In conclusion, parathyroid adenomas are a heterogeneous group of lesions in which the pattern of bcl-2 and MIB-1 protein expression ranges between that of normal parathyroid (bcl-2 positivity and MIB-1 negativity) and that of parathyroid carcinoma (bcl-2 negativity and MIB-1 positivity). The question of whether the finding of the MIB-1 positive-bcl-2 negative phenotype identifies a subgroup of clinically more aggressive adenomas remains to be established.
细胞增殖和程序性细胞死亡(凋亡)相关机制的调控改变可能在甲状旁腺肿瘤发生中起重要作用。我们通过免疫组织化学评估了一系列正常和肿瘤性甲状旁腺组织中作为凋亡调控标志物的bcl-2和p53蛋白以及作为细胞增殖标志物的MIB-1的表达。标本包括33个正常甲状旁腺、43个甲状旁腺腺瘤和3个甲状旁腺癌。当超过1%的细胞被MIB-1和p53染色,超过10%的细胞被bcl-2染色时,结果被判定为阳性。所有正常甲状旁腺均显示大量bcl-2阳性细胞(≥80%)、低增殖率(MIB-1)且无p53蛋白表达。24个(55%)腺瘤为bcl-2阳性;其中16个阳性细胞数量较多(>50%),免疫反应性在腺瘤内弥漫分布;8例显示带状染色模式,即染色细胞群被阴性细胞包围。19个腺瘤(45%)和所有癌均为bcl-2阴性。在所有癌和4个腺瘤(9%)中发现高增殖率(MIB-1);所有MIB-1阳性腺瘤均为bcl-2阴性。所有标本中p53均为阴性。在bcl-2阴性和bcl-2阳性以及MIB-1阳性和MIB-1阴性的腺瘤之间未发现血清钙和完整甲状旁腺激素水平以及肿瘤大小有显著差异。在甲状旁腺腺瘤中,观察到bcl-2阳性细胞百分比与血清钙水平之间呈负相关,但无统计学意义(p = 0.06)。总之,甲状旁腺腺瘤是一组异质性病变,其中bcl-2和MIB-1蛋白表达模式介于正常甲状旁腺(bcl-2阳性和MIB-1阴性)和甲状旁腺癌(bcl-2阴性和MIB-1阳性)之间。MIB-1阳性-bcl-2阴性表型的发现是否能识别出临床侵袭性更强的腺瘤亚组这一问题仍有待确定。